Clinical significance of histiocytes in the detection of endometrial adenocarcinoma and hyperplasia.
The purpose of this case-control study was to determine the clinical significance of histiocytes and normal endometrial cells as cytologic markers of adenocarcinoma or hyperplasia of the endometrium. Cervical-vaginal smears obtained in 102 patients with mean age 59.7 yr with abnormal uterine bleeding and endometrial pathology, and 101 controls with mean age 56.5 yr with postmenopausal bleeding and whose cytologic smear was negative, were evaluated. Histiocytes alone failed to predict either endometrial adenocarcinoma (odds ratio [OR], 1.02; 95% confidence interval [CI], 0.32-3.22) or hyperplasia (OR, 1.10; 95% CI, 0.37-3.30). The odds of endometrial carcinoma in symptomatic, postmenopausal women was three times greater in the presence of histiocytes with phagocytosis of acute inflammatory cells (PIC) (OR, 3.00; 95% CI, 1.16-7.70). Endometrial hyperplasia was more frequently observed when cervical smears contained normal endometrial cells (OR, 4.09; 95% CI, 1.14-14.67). Only histiocytes with PIC and normal endometrial cells carry a three- and fourfold greater likelihood of coexistent endometrial adenocarcinoma and hyperplasia, respectively. Such strong association may require endometrial biopsy or transvaginal ultrasonography to uncover lesional tissue in the endometrial cavity.
Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.
T N
TN
Nguyen
J L
JL
Bourdeau
A
A
Ferenczy
E L
EL
Franco
D000230:Adenocarcinoma / Q000145:classification / Q000473:pathology*; D000328:Adult; D016022:Case-Control Studies; D004714:Endometrial Hyperplasia / Q000473:pathology*; D016889:Endometrial Neoplasms / Q000145:classification / Q000473:pathology*; D005260:Female; D006644:Histiocytes; D006801:Humans; D008875:Middle Aged